Adicet Bio, Inc. (ACET) vs InterCure Ltd. (INCR)

A side-by-side comparison of Adicet Bio, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACET vs INCR

growth of $100 · dividends reinvested · last 8y
ACET -99.3% (-46.2%/yr)INCR -68.0% (-13.3%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$1$32
ACET INCR

ACET vs INCR: by the numbers

  • •INCR is the larger company ($63M vs $60M market cap).
  • •Both run net losses; ACET's is the smaller (0.00% vs -13.72% net margin).

Metrics side by side

Valuation

MetricACETINCR
P/S ratioN/A0.79
P/B ratio0.500.50
FCF yieldN/A11.71%

Profitability

MetricACETINCR
Gross margin0.00%14.40%
Operating margin0.00%2.49%
Net margin0.00%-13.72%
ROE-82.38%-8.80%
ROIC-79.68%-4.72%

Growth (annualized)

MetricACETINCR
Revenue CAGR (5Y)N/A32.71%
Total return CAGR (5Y)-44.24%-30.85%

Frequently asked

How have ACET and INCR total returns compared?
Over the past 5 years, ACET delivered -44.24% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.